How AI Is Redefining Work In Healthcare & Life Sciences

Some of the common challenges in AI adoption in healthcare & life sciences include:

• Data Privacy and Security: The sensitive nature of healthcare data, coupled with strict regulations like HIPAA and GDPR, creates significant challenges around governance and compliance.
• Data Quality and Integration: AI systems require high-quality, structured data for effective functioning. Many organizations struggle with fragmented or unstandardized data across systems.
• Regulatory and Ethical Concerns: The sector is heavily regulated, and organizations must navigate complex approval processes while ensuring ethical AI use, such as avoiding bias in algorithms.
• Infrastructure Limitations: Scaling AI requires robust digital infrastructure, including cloud computing and advanced analytics platforms, which some organizations lack.
• Workforce Readiness: AI-skilled professionals are in short supply, and resistance to change among existing staff can hinder adoption.
• Cost and ROI Uncertainty: Implementing AI solutions can be expensive, and organizations may hesitate due to unclear or delayed returns on investment.
• Interoperability Issues: AI systems must integrate seamlessly with existing technologies and workflows, which can create significant technical challenges.
• Trust and Transparency: Building trust in AI systems among clinicians, patients, and stakeholders is critical, especially when decisions are made by algorithms.

Alex points out that the real challenge of AI, however, lies in translating abstract concepts into practical, measurable value to drive adoption. This is especially difficult in decentralised organisations, where teams may adopt AI tools independently, which atomises risk and value, making them potentially more difficult to identify and manage. Effective AI governance requires clear internal guidelines and ongoing monitoring to ensure both off-the-shelf and custom models remain accurate and fit for purpose. As AI technologies evolve rapidly, organisations must build the internal capability to manage and measure AI’s risks and rewards.

This can help to create the mental space for teams to experiment. Many individuals may use AI tools like ChatGPT personally, while remaining hesitant to apply them professionally, often due to concerns around data protection, or a lack of understanding on how to do so in a safe manner.

At the same time, Alex says there’s a clear gap in knowledge and expectation. He recalls one instance where a client wanted to use AI to accelerate their patent application process. Upon further consultation, it became apparent that what they had envisioned was the automated documentation of early-stage concepts in their engineer’s brains. “I had to explain that we don’t have established brain-to-text interfaces, at least not yet,” he says. “The world of AI has evolved so quickly that what seemed like science fiction three years ago is now real, yet some people still over-estimate its current abilities.”

To scale AI effectively across large organisations, Alex says it’s essential to start from the basis of measuring return on investment. The key is to ensure that every instance of adoption is aimed at real business problems. This means starting with a clear problem statement and building a model in direct response. When AI is tied to business value, it’s easier to gain internal support and drive adoption through clear demonstrations of value.

Additionally, governance considerations must be built in from the very start, including ensuring data quality and questioning whether legacy data that feeds AI systems reflects the organisation’s current values. This is key, as governance after the fact is much more difficult to build, and may fail to counteract risks that arise during adoption.